Athenex to provide corporate and financial update for the second quarter 2022 on july 28, 2022

Buffalo, n.y., july 21, 2022 (globe newswire) -- athenex (nasdaq: atnx), a global biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies for the treatment of cancer and related conditions, today announced that the company will provide a corporate and financial update for the second quarter 2022 on thursday, july 28, 2022, before the market opens. athenex's management team will host a conference call and live audio webcast at 8:00 a.m. eastern time.
ATNX Ratings Summary
ATNX Quant Ranking